Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
about
Chemotherapy-related cognitive impairment in older patients with cancerPsychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovationsExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsImpact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body StudyDefault mode network as a potential biomarker of chemotherapy-related brain injuryCognitive problems among breast cancer survivors: loneliness enhances riskCognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Prevalence, mechanisms, and management of cancer-related cognitive impairment.Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine.Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.Self-reported cognitive concerns and abilities: two sides of one coin?Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.Cognitive function and fatigue after diagnosis of colorectal cancerCytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future researchClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsThe association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial.Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical StudyAssociation of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort studyHuman amniotic epithelial cells inhibit granulosa cell apoptosis induced by chemotherapy and restore the fertility.Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast CancerA feasibility study exploring the role of pre-operative assessment when examining the mechanism of 'chemo-brain' in breast cancer patientsCytokine genetic variations and fatigue among patients with breast cancer.Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancerCognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.Positive Affect and Inflammatory Activity in Breast Cancer Survivors: Examining the Role of Affective Arousal.Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.Neuroimaging, cancer, and cognition: state of the knowledge.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster.Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors.Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review.Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients.Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
P2860
Q26747612-95F84318-BFAB-48FE-92C7-39C116E7D07CQ27007708-AAD64F2E-6BA4-494C-9636-FE4F81155D96Q28075692-42D96710-08A1-4D2C-956F-31307343251BQ30758966-6C81EC80-50D7-481B-A008-E8C2B3B9B4CFQ30830124-7F425A3D-538E-48B7-87B5-77F0C1372CC8Q33358246-6D9D80C9-97A9-42D0-A742-271C5F13BF02Q33729085-24796789-9F23-4FCB-93BF-5C03DB1E9BD3Q33854977-6C19B090-5B9E-413A-B6DC-402488D0A01AQ34031141-F3B0F480-12B1-4982-BD1F-532E266586BDQ34036124-CE290909-DFB9-41C7-8122-991D015385D9Q34194470-A0BD82FC-252E-42E7-8B4F-CA676DA7550CQ34288191-77A57A7D-FCB1-4B30-9569-A50B9B77299CQ34402534-BC2A33E4-BA9F-48C0-9858-477EC43ABAFFQ34503992-B9B453BA-700A-4784-936F-C8A013B1C0B4Q34553654-30287FDE-3CD1-41BB-8D70-4963ABCBED81Q35067446-D30A0351-7F59-48E0-ABB5-F4C6FBEC38B1Q35164117-FF53B091-6512-43CB-A4F4-D7710F71BC39Q35446931-673783C4-0C01-4BB8-9836-891176A53A73Q35513395-A7DDC809-D634-417F-9AB5-BB42A9836E07Q35536611-279D462F-A855-484E-A774-7FE7F4C9A79EQ35775258-37BE0807-7DC7-4725-A38F-CA8D86384CAEQ35995038-EB6DD199-CF54-40AA-9135-DFCFEADFBA92Q36152838-F1372DA7-62EB-460B-91CD-7133FE84B3DBQ36173493-F90B58D1-1B79-4DE2-B170-41A8DD7023CBQ36754399-702CE4A1-EE80-4E26-8794-BA66D4050BA0Q36793285-71AC6A64-E7F8-42D1-AAC5-D384ADBC1B39Q36813475-A40D5D26-A137-42F9-8A2D-2A7AFC0DA1D8Q36901307-9035526D-E25C-4F45-AB3C-334A31F55E15Q37036767-45B587A6-C75D-49B3-8ABF-1C74368E6232Q37064264-40552E9F-0139-4F44-8B73-66131316156DQ37292321-167CA25C-9864-4FA6-BFA8-ECA473FAED26Q37431101-DB9231B7-5130-47D1-991F-7E8CF5608D64Q37540122-F6401579-38EB-4CCB-AAC7-0EC1008EBA74Q37576583-8D065D8B-959C-4FAA-A1CB-95053EDA39FCQ37633785-3164BF31-4C8B-43FA-9CF9-21988668CE1AQ37712562-251D62E0-58AC-461B-8D69-159B58C18E16Q38150812-B533C80A-0AE0-4673-AAE5-24A6C4AEEEDBQ38594867-F0F272E3-4F75-4B55-BBD7-F37C911C62B7Q38786134-E066547C-E90B-410B-8396-F5245AEBF638Q38848380-2C564975-2445-4FD8-9C66-9B4AB3AF33B5
P2860
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@ast
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@en
type
label
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@ast
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@en
prefLabel
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@ast
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@en
P2093
P2860
P1476
Does tumor necrosis factor-alp ...... otherapy cerebral dysfunction?
@en
P2093
D H S Silverman
Patricia A Ganz
S A Castellon
P2860
P304
P356
10.1016/J.BBI.2012.07.015
P478
P577
2012-08-03T00:00:00Z